Skip to main content
. 2011 Jul 1;118(13):3489–3498. doi: 10.1182/blood-2011-03-339077

Table 3.

NCI responses at respective assessment time points and best response achieved for all patients

No. on Rx/ITT Evaluation cycle
3 cycles, no. (%) 54/60* 9 cycles, no. (%) 43/60 15 cycles, no. (%) 38/60 21 cycles, no. (%) 35/60 Best response, no. (%) 60
Response
    CR 0 1 (2) 3 (5) 5 (8) 6 (10)
    CRi 0 0 2 (3) 3 (5) 3 (5)
    nPR 0 6 (10) 4 (7) 5 (8) 4 (7)
    PR 24 (40) 27 (45) 27 (45) 22 (37) 26 (43)
ORR 24 (40) 34 (57) 36 (60) 35 (58) 39 (65)
    DC(PR) 0 1 0 1

Rx indicates therapy; ITT, intention-to-treat; nPR, nodular partial response; and DC(PR), discontinued in PR.

*

One patient not evaluable.

2008 NCI working group criteria for response.